Zydus Lifesciences LimitedNSE: ZYDUSLIFE

Press Release Oct 08 2021

· Issued by Zydus Lifesciences Limited

Filed with NSE · · 6 pages · English

Release

Cadila Healthcare Limited has informed the Exchange regarding a press release dated October 08, 2021, titled "Fortress Biotech and Cyprium Therapeutics with support from its licensing partner Sentynl Therapeutics, Inc. a wholly owned subsidiary of Cadila Healthcare Limited ( Zydus ) Announce Positive Clinical Data for CUTX-101, Copper Histidinate for the treatment of Menkes Disease".

Zydus Lifesciences Limited on 6ix

Earlier from Zydus Lifesciences

Later from Zydus Lifesciences

All Zydus Lifesciences news releases